Technological Capabilities
SciAnda (Changshu) provides complete API manufacturing process development and organic chemistry pathway synthesisdesignservices, from the early stage synthesis of a new chemical entity tocommerciallarge-scale production. Its technical capabilities in process research and development are comprehensive.
Manufacturing
The entire plant of SciAnda (Changshu) is designed and constructed in accordance with the new “Pharmaceutical GoodManufacturing Practice” standards prescribed by the China Food and Drug Administration (CFDA). The site has state-of-the-art facilities that conform to international cGMPs (Current Good Manufacturing Practices) standards that allow the development and production of high quality APIs at favorable pricing that adhere to the rules and regulation of every country’s patent laws.
Products and Services
Development and promotion of active pharmaceutical ingredients (API) manufactured by SciAnda and provision of active pharmaceutical ingredients that are of high-value and high-quality and not in conflict with patent for customers of generic-drugs and original-drugs development. Mainly focusing on small molecules organic synthesis.
Active and timely development of China’s market of active pharmaceutical ingredients, actively developing products and gaining market share with Chinese pharmaceutical manufacturers, and at the same time providing contract manufacturing for international pharmaceutical manufacturers.